Drug Approval Concerns
The discussion highlights significant concerns regarding the approval of a new drug, emphasizing the lack of substantial symptom improvement and the alarming side effects, particularly amyloid-related imaging abnormalities. With up to 30% of patients potentially experiencing severe adverse effects, including brain swelling, the risks are particularly pronounced for those with a genetic predisposition to Alzheimer's. This raises critical questions about the drug's endorsement by the medical community.In this clip
From this podcast
Psychiatry & Psychotherapy Podcast
Alzheimer’s Dementia
Related Questions